Mynd.ai, Inc. rose 15.0% on Wednesday, November 11, 2026, on 266,800 shares. No headline about MYND came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Mynd.ai, Inc. (MYND:NYSEMKT) closed at $0.216 on November 13, 2026, down 6.13% on the day. The stock trades 67.5% below its 52-week high of $0.664 and 34.1% above its 52-week low of $0.161. Over the past year, it lost 63.4%. Mynd.ai, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, MYND closed higher on 99 days (39%). Its best day was May 29, 2026 (+114.34%) and its worst was June 1, 2026 (-34.75%). The stock moved 10% or more in a single session 30 times. It opened at least 5% above the previous day's high 10 times.
MYND Life Sciences Inc is a life science based, neuro-pharmaceutical drug development company. It is advancing medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on major depressive disorder. The company's mission is to further research linking depression and inflammation at the genetic and cellular level to develop a pharmaceutical treatment utilizing compounds found in psychedelics with the initial focus being on psilocybin and its various analogs.
Find more stocks like MYND with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.